Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Orrick ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Dusting The Regulatory Framework – French Competition Authority Seeks To Liberalize Distribution Of Drugs And Private Medical Biology
On April 4, 2019, just three months after the publication of the European Commission (EC) report on "Competition enforcement in the pharmaceutical sector,"
United States
15 May 2019
2
Even Bambi Is A Trade Secret: Eastern District Of Texas Finds That Lineage And Genetic Information Of Deer Are Trade Secrets, Grants Preliminary Injunction
As surprising as it may be to city dwellers, the deer farming industry generates $3 billion per year for the U.S. economy.
United States
22 Aug 2017
3
Ninth Circuit Smells A Rat And Reinstates Claim That Pharmaceutical Company Failed To Disclose Cancers In Animal Testing
The Ninth Circuit recently revived a securities class action against Arena Pharmaceuticals issuing a decision with important guidance to pharmaceutical companies...
United States
17 Nov 2016
4
Third Circuit Rules That Antitrust Standing Is Properly Challenged Under Rule 12(B)(6) For Failure To State A Claim, Not Under Rule 12(B)(1) For Lack Of Subject Matter Jurisdiction
On September 7, 2016, the Third Circuit ruled that a district court erred in granting a Fed. R. Civ. P. 12(b)(1) motion to dismiss federal antitrust claims for lack of subject matter jurisdiction...
United States
14 Sep 2016
5
Quo Vadis FTC: What Does The Commission's Complaint Against Endo Pharmaceuticals And Others Say About The Future Of Post-Actavis Hatch-Waxman Litigation And Reverse Payment Settlements?
This alert, the title of which is adapted from a March 30, 2016 FTC Staff Attorney blog post, considers the FTC's first lawsuit challenging a so-called "no-AG" agreement.
United States
15 Apr 2016
6
N.D. Cal Interprets The Biological Price Competition Act
On March 19, the Northern District of California became the first court to interpret two key provisions of the Biological Price Competition Act...
United States
9 Apr 2015
7
Sandoz Was Disinvited To The Patent Dance: The Federal Circuit’s First Interpretation Of The BPCIA Will Have To Wait
Since the 1984 enactment of the Drug Price Competition and Patent Term Restoration Act, Hatch-Waxman litigation has dominated the sphere of life-sciences patent litigation.
United States
6 Jan 2015
8
Why Make Razors, When The Money’s In Blades?
Now here’s a scenario that would offer Count Dracula a sweet tooth – er, a sweet fang.
United States
4 Jun 2014
9
Green Chemistry And Trade Secrets: California Leads Chemical Disclosure Movement, As Companies Wrestle With Options For Protection
Earlier this year, we picked mandatory public disclosure laws as a trend to watch in 2014.
United States
19 Feb 2014
Links to Result pages
 
1